Research vault
Human studyPublished 2010· Blood Sugar & Diabetes

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus

Read the original on PubMed 20711718
Plain-language summary

Longitudinal genetic study in type 1 diabetes patients showing that a polymorphism in the carnosinase gene predicts who progresses from diabetic nephropathy to end-stage renal disease and who dies sooner. Direct human evidence that endogenous carnosine handling shapes diabetic outcomes.

Key takeaways
  • Genetic variant predicts renal progression in T1DM.
  • Connects carnosine biology to hard clinical endpoints.
  • Motivates carnosine-augmenting strategies in nephropathy.
About this summary

The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.

Related in this category